The study elucidates the potential of CSO as a therapeutic agent in managing obesity-associated metabolic disorders by restoring iron homeostasis and fostering gut health. These results highlight the interconnectedness of dietary fat, iron metabolism, and microbiome dynamics in the pathophysiology of obesity-related diabetes, suggesting a multifaceted approach to treatment strategies.
Li et al. (Wed,) studied this question.